Does high-dose extended course cyclophosphamide and methylprednisolone pulse therapy have a role in the management of systemic sclerosis-related interstitial lung disease?
| Image |  |
|---|---|
| Description | scientific article published on 15 October 2016 |
| Author/s |
author: Paul Emery Maya Hema Buch |
| Publication date | October 15, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Access work | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |